This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodriguez, G. Articles by Rosadini, G. Search for Related Content PubMed PubMed Citation Articles by Rodriguez, G. Articles by Rosadini, G.

Stroke, Vol 25, 831-836, Copyright © 1994 by American Heart Association

ARTICLES

Regional cerebral blood flow in familial hypercholesterolemia

G Rodriguez, S Bertolini, F Nobili, A Arrigo, P Masturzo, N Elicio, M Gambaro and G Rosadini
Department of Motor Science (Neurophysiopathology), University of Genova, Italy.

BACKGROUND AND PURPOSE: Although epidemiologic investigations are trying to clarify the role of plasma lipid concentrations (primarily cholesterol and its subfractions) as risk factors for both ischemic and hemorrhagic stroke, little information is available regarding the effect of sustained hypercholesterolemia on cerebral perfusion. METHODS: Regional cerebral blood flow (CBF) was measured by the 133Xe inhalation method in 25 heterozygous patients (four untreated) affected with familial hypercholesterolemia. In 15 patients regional CBF was repeated 20 minutes after intravenous administration of acetazolamide (10 mg/kg body wt) to evaluate cerebrovascular reactivity. Correlations among cerebral perfusion data, present or pretreatment plasma lipid concentrations, and certain other clinical features were assessed by ANOVA. RESULTS: Both basal regional CBF and cerebrovascular reactivity were normal in the vast majority of patients compared with age- and sex- matched normal control subjects. CBF was significantly dependent on pretreatment low-density lipoprotein cholesterol (LDL-C) concentration (P = .005) and the presence of symptomatic ischemic heart disease (P = .015). CBF was only slightly dependent on age (P = .05) and was not dependent on either lipoprotein(a) or present LDL-C concentration. CBF did not differ between treated and untreated patients, and the perfusional increase induced by acetazolamide was not related to any other variable. CONCLUSIONS: Cerebral perfusion and cerebrovascular reactivity were maintained within the normal range despite long- lasting, severe hypercholesterolemia, even if a somewhat lower CBF was found in those patients with the highest LDL-C pretreatment levels. These results are in accord with the epidemiologic data that implicate hypercholesterolemia as a minor risk factor, if a risk factor at all, for intracranial atherosclerosis and ischemic stroke.

This article has been cited by other articles:

				P. J. van Laar, Y. van der Graaf, W. P. T. M. Mali, J. van der Grond, and J. Hendrikse Effect of Cerebrovascular Risk Factors on Regional Cerebral Blood Flow Radiology, December 1, 2007; 246(1): 198 - 204. [Abstract] [Full Text] [PDF]

				A. F. van Raamt, A. P. A. Appelman, W. P. T. M. Mali, Y. van der Graaf, and For the SMART Study Group Arterial Blood Flow to the Brain in Patients with Vascular Disease: The SMART Study. Radiology, August 1, 2006; 240(2): 515 - 521. [Abstract] [Full Text] [PDF]

				S. L. M. Bakker, F.-E. de Leeuw, P. J. Koudstaal, A. Hofman, and M. M. B. Breteler Cerebral CO2 reactivity, cholesterol, and high-density lipoprotein cholesterol in the elderly Neurology, February 22, 2000; 54(4): 987 - 989. [Abstract] [Full Text] [PDF]